Instituto Dante Pazzanese de Cardiologia   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: São Paulo Brazil (1954)

Organization Overview

First Clinical Trial
2004
NCT00123916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Instituto Dante Pazzanese de Cardiologia | Instituto Date Pazzanese de Cardiologia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chagas Disease (Phase 3)

Coronary Artery Disease (Phase 4)

Heart Diseases (Phase 3)

Infarction (Phase 4)

Kidney Diseases (Phase 4)

Myocardial Infarction (Phase 4)

Trypanosomiasis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5